I have non-valvular atrial fibrillation and have been prescribed Xarelto® (rivaroxaban) to reduce my risk of stroke.

What is Xarelto (rivaroxaban) 15mg or 20mg tablet?

Xarelto contains the active substance rivaroxaban and is used in adults to:

  • Prevent blood clots in brain (stroke) and other blood vessels in your body if you have a form of irregular heart rhythm called non-valvular atrial fibrillation.
  • Treat blood clots in the veins of your legs (deep vein thrombosis) and in the blood vessels of your lungs (pulmonary embolism), and to prevent blood clots from re-occurring in the blood vessels of your legs and/or lungs.

Xarelto belongs to a group of medicines called antithrombotic agents. It works by blocking a blood clotting factor (factor Xa) and thus reducing the tendency of the blood to form clots.

How to take Xarelto 15mg or 20mg tablets?

To prevent blood clots in brain (stroke) and other blood vessels in your body:

  • The recommended dose is one tablet of Xarelto 20mg once a day to be taken with food.
  • If you have kidney problems, the dose may be reduced to one tablet of Xarelto 15mg once a day, to be taken with food.

Please refer to the patient information leaflet for more information. The Patient Information Leaflet (PIL) is the leaflet included in the pack with your medicine.

To access the latest version of the Xarelto 2.5mg, 10mg and 15/20 mg Summary of Product Characteristics (SmPC) as well as Xarelto Patient Information Leaflet (PIL), please click on the following link eMC Widget

Report Possible Side Effects

This medicine is subject to additional monitoring. This will allow quick identification of new safety information.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store.

You can also report side effects and quality complaints to Bayer Plc. Further information is available on the “contact” tab at www.bayer.co.uk.

By reporting side effects you can help provide more information on the safety of this medicine.